BioXcel Therapeutics
BTAI
NZ$2.67
Share price
-6.47%
Change (1 day)
-91.59%
Change (1 year)
Categories
BioXcel Therapeutics (BTAI) - Total assets
Total assets on the balance sheet as of March 2025 : NZ$64.7 Million
According to BioXcel Therapeutics's latest financial reports the company's total assets are NZ$64.7 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BioXcel Therapeutics - Total assets on balance sheet (from 2017 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | NZ$0.11 B | -64.06% |
| 2022-12-31 | NZ$0.32 B | -7.51% |
| 2021-12-31 | NZ$0.35 B | 15% |
| 2020-12-31 | NZ$0.30 B | 464.1% |
| 2019-12-31 | NZ$54.03 M | -16.77% |
| 2018-12-31 | NZ$64.92 M | 3302.88% |
| 2017-12-31 | NZ$1.9 M | 18779.8% |
| 2016-12-31 | NZ$0.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$0.40 B | 529.72% | 🇺🇸 USA |